Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Figure out How to Keep up with and Clean Your Brilliant Bed for Ideal Execution - 2In the background: Visiting Notable Film Areas All over the Planet
- 35 Morning Schedules That Stimulate Your Day
- 4The Best Portable Applications for Emotional wellness and Prosperity
- 5Manual for extravagance SUVs for seniors
- A few Exemplary Chinese Dishes, Which Are Famous Around the world
- How effective is the flu shot this year? New report shows promising results
- Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests
- Doctor's orders: Eat ice cream, and other tips for a long and healthy life
- Five held on suspicion of planning attack on German Christmas market
- Figure out How to Consolidate Cutting edge innovations in Senior's SUVs
- What Yogurt Types Do You Know
- The Best Games On the planet
- Sophie Kinsella, 'Confessions of a Shopaholic' author, dies at 55 after battle with cancer
